Abstract: A surgical trainer facilitates the training of a medical practitioner in one or more surgical includes one or more layers of healable synthetic tissues. The healable synthetic tissue includes healable material configured to facilitate a re-bonding of the healable synthetic tissues to their original shape after an incision is made to the healable synthetic tissues.

Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.

Abstract: The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, wherein the cap may include a central longitudinal axis, a first end having a first cross-sectional dimension, and a second end having a second cross-sectional dimension larger than the first cross-sectional dimension.

Abstract: An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration.

Abstract: The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, which may include a curved sidewall extending radially outward. The curved sidewall may include a protrusion.

Abstract: Techniques are described herein that are capable of providing security for code between a code generator and a compiler. The code generator generates source code. The code generator generates a first checksum of a file that includes the source code. The code generator provides the first checksum to the compiler via a secure channel. The compiler generates a second checksum of the file that includes the source code. The compiler determines whether to compile the source code based at least in part on whether the first checksum and the second checksum are the same. The first checksum and the second checksum being the same indicates that the source code is to be compiled. The first checksum and the second checksum being different indicates that the source code is not to be compiled.

Abstract: The authenticity of a compressed archive is verified without decompressing the files and/or directories contained therein and without impeding existing archive reader tools and utilities. A container is produced that includes a signature component and a compressed archive component. The signature component contains a digital signature of the compressed archive and the compressed archive component contains the compressed archive. The signature component and the compressed archive component are constructed as independent components so that existing software tools that operate on a compressed archive can still function in their normal course of operation.

Abstract: The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, which may include a curved sidewall extending radially outward. The curved sidewall may include a protrusion.

Abstract: A system and method for providing a credit card with multiple lines of credit. One of the disclosed methods include, for example, analyzing credit information of a cardholder to determine a level of risk associated with the cardholder; establishing a general purpose credit line based on the determined level of risk associated with the cardholder, the general purpose credit line being set as a revolving credit line; establishing a private label credit line based on the determined level of risk associated with the cardholder, the private label credit line being set as a revolving credit line; and issuing the credit card to the cardholder with the established general purpose credit line and private label credit line.

Abstract: The authenticity of a compressed archive is verified without decompressing the files and/or directories contained therein and without impeding existing archive reader tools and utilities. A container is produced that includes a signature component and a compressed archive component. The signature component contains a digital signature of the compressed archive and the compressed archive component contains the compressed archive. The signature component and the compressed archive component are constructed as independent components so that existing software tools that operate on a compressed archive can still function in their normal course of operation.